Latest News by Industry
Royalty Pharma plc [RPRX] has reported $2.4 billion in revenue for year ended Dec 31, 2023.
Also Read: PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
The company said in a filing before the Securities and Exchange Commission that its profit for the year was $1.7 billion.
Based in New York, New York, Royalty Pharma plc operates in the Manufacturing sector.
Related Articles: Royalty Pharma Announces Expansion of Senior Leadership Team Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference Royalty Pharma plc [RPRX] posts $220K loss as revenue rises 7.00% to $573K
USInMinutes/IndiaInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to more news alerts here. Although care is taken to ensure accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications